학술논문

North Central Cancer Treatment Group (NCCTG) N0432: Phase II trial of docetaxel with capecitabine and bevacizumab as first-line chemotherapy for patients with metastatic breast cancer
Document Type
Article
Source
In: Annals of Oncology. (Annals of Oncology, 9 November 2009, 21(2):269-274)
Subject
Language
English
ISSN
15698041
09237534